Clinical trials
Enrolling by invitation trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
146 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 8 |
| 2022 | 16 |
| 2023 | 21 |
| 2024 | 38 |
| 2025 | 37 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 146 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 6 |
| Sanofi | 3 |
| Sarepta Therapeutics, Inc. | 3 |
| University Hospital Tuebingen | 3 |
| University Medical Center Goettingen | 3 |
| Vertex Pharmaceuticals Incorporated | 3 |
| Anette Buyken | 2 |
| BioMarin Pharmaceutical | 2 |
| Charite University, Berlin, Germany | 2 |
| LMU Klinikum | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myotonic Dystrophy | 6 |
| Angioedemas, Hereditary | 5 |
| Epilepsy | 5 |
| Hemophilia A | 4 |
| Seizures | 4 |
| Aortic Valve Stenosis | 3 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus | 3 |
| Genetic Diseases, Inborn | 3 |
| Hematologic Neoplasms | 3 |
Trials
Showing 1 to 25 of 146. Each trial links to its page on Pharma Observatory.
46 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.